• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CVRX, INC. BAROSTIM NEO2; IMPLANTABLE PULSE GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CVRX, INC. BAROSTIM NEO2; IMPLANTABLE PULSE GENERATOR Back to Search Results
Model Number 2104
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Low Blood Pressure/ Hypotension (1914); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 12/19/2022
Event Type  Injury  
Manufacturer Narrative
While analysis was unable to be performed as the device was not returned, per the opinion of the physician, the root cause of the event was contributed to by the anesthesia protocol during the procedure.The device history and sterilization record for this device serial number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.Health effect clinical code 4581: suggested codes are "volume depletion" and "elevated creatinine." cvrx id#: (b)(4).
 
Event Description
A barostim system was implanted on (b)(6) 2022.Shortly after, the patient experienced volume depletion with an elevated creatinine, along with blood pressure of 70/50.Medications were stopped, and a dobutamine drip was administered.A heart catheterization was performed on (b)(6) 2023.After the heart catheterization, the patient was stable, blood pressure had improved, and creatinine had decreased from 4.9 to 3.9.No additional adverse event was reported at the second follow-up.In the opinion of the physician, the anesthesia used with the procedure contributed to the event.The anesthesia protocol was sevoflurane at 1/2 mac, versed and either fentanyl or remifentanil.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAROSTIM NEO2
Type of Device
IMPLANTABLE PULSE GENERATOR
Manufacturer (Section D)
CVRX, INC.
9201 west broadway avenue
suite 650
minneapolis MN 55445
Manufacturer (Section G)
CVRX, INC.
9201 west broadway avenue
suite 650
minneapolis MN 55445
Manufacturer Contact
sarah hicks
9201 west broadway avenue
suite 650
minneapolis, MN 55445
MDR Report Key16292823
MDR Text Key308735855
Report Number3007972010-2023-00003
Device Sequence Number1
Product Code DSR
UDI-Device Identifier00859144004623
UDI-Public(01)00859144004623(17)240311
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180050
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/03/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/11/2024
Device Model Number2104
Device Catalogue Number100065-202
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/05/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/11/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
Patient SexMale
-
-